Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 
FDA Approves Mitapivat for Anemia in Thalassemia Patients 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans 
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s 
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market 
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors 
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan 
The disease known as monkeypox has surfaced recently due to one reported case found in the United Kingdom. This would be the second time in two years that cases of this disease have been reported in the country again.
The Independent reports that the patient contracted the disease after traveling to Nigeria. They were immediately transferred to the infectious disease center in London. Public Health England stated that they are also working to contact the people who were on the same flight as the patient as well as people whom the patient came into close contact with. They are prepared to take precautionary measures and monitor them in the possibility that they also contract the disease.
The first case of monkeypox in the United Kingdom was in September of 2018, where three people were infected with the virus. Two out of the three people had also come from Africa while the third was a healthcare worker who attended one of the first two cases.
However, the PHE further stated that the monkeypox virus is not very contagious and thus does not spread easily between people. It usually poses a low risk to the general public. Patients who have been infected by this disease normally recover after several weeks. However, there have been some cases where it was fatal.
PHE consultant microbiologist Dr. Meera Chand stated, “PHE and NHS have well established and robust infection control procedures for dealing with cases of imported infectious disease and these will strictly be followed to minimize the risk of transmission.”
Monkeypox is a disease that originates from central and western African countries. While it is not really contagious, it can still be spread by touching items that the infected person has used. The virus can also be transmitted by touching the scabs or spots or being in close proximity with the infected person if they cough or sneeze.
The symptoms of monkeypox include fever, swollen lymph nodes, chills, fatigue, muscle pains, back pains, and chills. As the disease progresses, rashes will begin to form and it usually starts with parts of the face before it spreads to other parts of the body. The rash will eventually change into spots or scabs that eventually fall off.
Treatment for monkeypox takes place in specialist hospitals.
